187 related articles for article (PubMed ID: 26228529)
1. Immunosuppressive properties of Wharton's jelly-derived mesenchymal stromal cells in vitro.
He H; Nagamura-Inoue T; Takahashi A; Mori Y; Yamamoto Y; Shimazu T; Tsunoda H; Tojo A
Int J Hematol; 2015 Sep; 102(3):368-78. PubMed ID: 26228529
[TBL] [Abstract][Full Text] [Related]
2. Comparative Analyses of Immunosuppressive Characteristics of Bone-Marrow, Wharton's Jelly, and Adipose Tissue-Derived Human Mesenchymal Stem Cells.
Karaöz E; Çetinalp Demircan P; Erman G; Güngörürler E; Eker Sarıboyacı A
Turk J Haematol; 2017 Aug; 34(3):213-225. PubMed ID: 27610554
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
[TBL] [Abstract][Full Text] [Related]
4. Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis.
Donders R; Vanheusden M; Bogie JF; Ravanidis S; Thewissen K; Stinissen P; Gyselaers W; Hendriks JJ; Hellings N
Cell Transplant; 2015; 24(10):2077-98. PubMed ID: 25310756
[TBL] [Abstract][Full Text] [Related]
5. Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor.
Najar M; Raicevic G; Boufker HI; Fayyad-Kazan H; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Tissue Eng Part A; 2010 Nov; 16(11):3537-46. PubMed ID: 20597819
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory effects of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on differentiation, maturation and endocytosis of monocyte-derived dendritic cells.
Saeidi M; Masoud A; Shakiba Y; Hadjati J; Mohyeddin Bonab M; Nicknam MH; Latifpour M; Nikbin B
Iran J Allergy Asthma Immunol; 2013 Mar; 12(1):37-49. PubMed ID: 23454777
[TBL] [Abstract][Full Text] [Related]
7. Human Wharton's Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-α and Interferon-γ Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic Patients.
Mrahleh MA; Matar S; Jafar H; Wehaibi S; Aslam N; Awidi A
Front Immunol; 2021; 12():732549. PubMed ID: 34650558
[TBL] [Abstract][Full Text] [Related]
8. Wharton's Jelly Mesenchymal Stromal Cells from Human Umbilical Cord: a Close-up on Immunomodulatory Molecules Featured In Situ and In Vitro.
Corsello T; Amico G; Corrao S; Anzalone R; Timoneri F; Lo Iacono M; Russo E; Spatola GF; Uzzo ML; Giuffrè M; Caprnda M; Kubatka P; Kruzliak P; Conaldi PG; La Rocca G
Stem Cell Rev Rep; 2019 Dec; 15(6):900-918. PubMed ID: 31741193
[TBL] [Abstract][Full Text] [Related]
9. Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes.
Najar M; Raicevic G; Jebbawi F; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Immunol Lett; 2012 Aug; 146(1-2):50-6. PubMed ID: 22575528
[TBL] [Abstract][Full Text] [Related]
10. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues.
Yoo KH; Jang IK; Lee MW; Kim HE; Yang MS; Eom Y; Lee JE; Kim YJ; Yang SK; Jung HL; Sung KW; Kim CW; Koo HH
Cell Immunol; 2009; 259(2):150-6. PubMed ID: 19608159
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of non-muscle myosin II leads to G0/G1 arrest of Wharton's jelly-derived mesenchymal stromal cells.
Sharma T; Kumari P; Pincha N; Mutukula N; Saha S; Jana SS; Ta M
Cytotherapy; 2014 May; 16(5):640-52. PubMed ID: 24210786
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord.
Manochantr S; U-pratya Y; Kheolamai P; Rojphisan S; Chayosumrit M; Tantrawatpan C; Supokawej A; Issaragrisil S
Intern Med J; 2013 Apr; 43(4):430-9. PubMed ID: 23176558
[TBL] [Abstract][Full Text] [Related]
13. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.
Devito L; Badraiq H; Galleu A; Taheem DK; Codognotto S; Siow R; Khalaf Y; Briley A; Shennan A; Poston L; McGrath J; Gentleman E; Dazzi F; Ilic D
Regen Med; 2014; 9(6):723-32. PubMed ID: 25431909
[TBL] [Abstract][Full Text] [Related]
14. Immunological impact of Wharton's Jelly mesenchymal stromal cells and natural killer cell co-culture.
Najar M; Fayyad-Kazan M; Meuleman N; Bron D; Fayyad-Kazan H; Lagneaux L
Mol Cell Biochem; 2018 Oct; 447(1-2):111-124. PubMed ID: 29380244
[TBL] [Abstract][Full Text] [Related]
15. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord.
Hsieh JY; Fu YS; Chang SJ; Tsuang YH; Wang HW
Stem Cells Dev; 2010 Dec; 19(12):1895-910. PubMed ID: 20367285
[TBL] [Abstract][Full Text] [Related]
16. Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells.
Donders R; Bogie JFJ; Ravanidis S; Gervois P; Vanheusden M; Marée R; Schrynemackers M; Smeets HJM; Pinxteren J; Gijbels K; Walbers S; Mays RW; Deans R; Van Den Bosch L; Stinissen P; Lambrichts I; Gyselaers W; Hellings N
Stem Cells Dev; 2018 Jan; 27(2):65-84. PubMed ID: 29267140
[TBL] [Abstract][Full Text] [Related]
17. Immunological properties of extraembryonic human mesenchymal stromal cells derived from gestational tissue.
Stubbendorff M; Deuse T; Hua X; Phan TT; Bieback K; Atkinson K; Eiermann TH; Velden J; Schröder C; Reichenspurner H; Robbins RC; Volk HD; Schrepfer S
Stem Cells Dev; 2013 Oct; 22(19):2619-29. PubMed ID: 23711207
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO.
Tipnis S; Viswanathan C; Majumdar AS
Immunol Cell Biol; 2010; 88(8):795-806. PubMed ID: 20386557
[TBL] [Abstract][Full Text] [Related]
19. B7‑H1‑mediated immunosuppressive properties in human mesenchymal stem cells are mediated by STAT‑1 and not PI3K/Akt signaling.
Jang IK; Jung HJ; Noh OK; Lee DH; Lee KC; Park JE
Mol Med Rep; 2018 Aug; 18(2):1842-1848. PubMed ID: 29901104
[TBL] [Abstract][Full Text] [Related]
20. A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment.
De Bruyn C; Najar M; Raicevic G; Meuleman N; Pieters K; Stamatopoulos B; Delforge A; Bron D; Lagneaux L
Stem Cells Dev; 2011 Mar; 20(3):547-57. PubMed ID: 20923277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
